These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22198679)

  • 1. Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis.
    Safdar A
    Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1883-7. PubMed ID: 22198679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada.
    Aznar ML; Marras TK; Elshal AS; Mehrabi M; Brode SK
    BMC Pharmacol Toxicol; 2019 Jun; 20(1):37. PubMed ID: 31159865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases.
    Yagi K; Ishii M; Namkoong H; Asami T; Iketani O; Asakura T; Suzuki S; Sugiura H; Yamada Y; Nishimura T; Fujiwara H; Funatsu Y; Uwamino Y; Kamo T; Tasaka S; Betsuyaku T; Hasegawa N
    BMC Infect Dis; 2017 Aug; 17(1):558. PubMed ID: 28793869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.
    Namkoong H; Morimoto K; Nishimura T; Tanaka H; Sugiura H; Yamada Y; Kurosaki A; Asakura T; Suzuki S; Fujiwara H; Yagi K; Ishii M; Tasaka S; Betsuyaku T; Hoshino Y; Kurashima A; Hasegawa N
    BMC Infect Dis; 2016 Aug; 16():396. PubMed ID: 27506679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.
    Davis KK; Kao PN; Jacobs SS; Ruoss SJ
    BMC Pulm Med; 2007 Feb; 7():2. PubMed ID: 17319962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease.
    Jhun BW; Yang B; Moon SM; Lee H; Park HY; Jeon K; Kwon OJ; Ahn J; Moon IJ; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistant pneumonia treated with aerosolized amikacin in a patient with acute renal insufficiency.
    Bawany MZ; Saeed B; Sodeman T; Mutgi A; Duggan JM
    Am J Ther; 2013; 20(6):e710-2. PubMed ID: 21192243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and tolerability of amikacin administered as BAY41-6551 aerosol in mechanically ventilated patients with gram-negative pneumonia and acute renal failure.
    Luyt CE; Eldon MA; Stass H; Gribben D; Corkery K; Chastre J
    J Aerosol Med Pulm Drug Deliv; 2011 Aug; 24(4):183-90. PubMed ID: 21361783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized amikacin in the treatment of Pseudomonas pneumonia in the nursing home setting.
    Standridge JB; Aliff CL
    South Med J; 2001 Feb; 94(2):244-6. PubMed ID: 11235044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient].
    Prevotat A; Bonne S; Veziris N; Senneville E; Yazdanpanah Y; Legout L
    Med Mal Infect; 2011 Aug; 41(8):446-8. PubMed ID: 21435808
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.
    Olivier KN; Griffith DE; Eagle G; McGinnis JP; Micioni L; Liu K; Daley CL; Winthrop KL; Ruoss S; Addrizzo-Harris DJ; Flume PA; Dorgan D; Salathe M; Brown-Elliott BA; Gupta R; Wallace RJ
    Am J Respir Crit Care Med; 2017 Mar; 195(6):814-823. PubMed ID: 27748623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
    Hu FR; Luh KT
    Ophthalmology; 1998 Feb; 105(2):269-72. PubMed ID: 9479286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of IV amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease.
    Ellender CM; Law DB; Thomson RM; Eather GW
    Respirology; 2016 Feb; 21(2):357-62. PubMed ID: 26581837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease.
    Lee SFK; Laughon BE; McHugh TD; Lipman M
    Curr Opin Pulm Med; 2019 May; 25(3):271-280. PubMed ID: 30865034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trojan horse strategy to deliver amikacin to mycobacterial granulomas.
    Ovrutsky AR; Kartalija M; Bai X; Chan ED
    Am J Respir Crit Care Med; 2011 Oct; 184(7):860; author reply 860-1. PubMed ID: 21965019
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetics and toxicity of liposomal and conventional amikacin in a patient with multidrug-resistant tuberculosis.
    Whitehead TC; Lovering AM; Cropley IM; Wade P; Davidson RN
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):794-7. PubMed ID: 9923523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily dosing of amikacin for treatment of
    Lee H; Sohn YM; Ko JY; Lee SY; Jhun BW; Park HY; Jeon K; Kim DH; Kim SY; Choi JE; Moon IJ; Shin SJ; Park HJ; Koh WJ
    Int J Tuberc Lung Dis; 2017 Jul; 21(7):818-824. PubMed ID: 28633708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled antibiotics for the treatment of pneumonia.
    Schreiber MP; Shorr AF
    Curr Opin Pulm Med; 2019 May; 25(3):289-293. PubMed ID: 30562188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosolized antibiotics in mechanically ventilated patients: delivery and response.
    Palmer LB; Smaldone GC; Simon SR; O'Riordan TG; Cuccia A
    Crit Care Med; 1998 Jan; 26(1):31-9. PubMed ID: 9428540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia.
    Niederman MS; Chastre J; Corkery K; Fink JB; Luyt CE; García MS
    Intensive Care Med; 2012 Feb; 38(2):263-71. PubMed ID: 22147112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.